ニュース

モデルナ、米国FDAより新型コロナウイルスワクチン「mNEXSPIKE(R)」の ...
モデルナは、米国食品医薬品局（FDA）が新型コロナウイルス感染症（COVID-19）に対する新しいワクチン「mNEXSPIKE ...
モデルナ、米FDAより新型コロナウイルスワクチン「mNEXSPIKE」の製造 ...
【プレスリリース】発表日:2025年06月05日モデルナ、米国FDAより新型コロナウイルスワクチン「mNEXSPIKE(R)」の製造販売承認取得この資料は、モデルナ（マサチューセッツ州ケンブリッジ）が2025年5月31日（現地時間）に発表したものを日 ...
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
Clinical Advisor1 日
FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...
FDA grants limited approval to new Covid vaccine from Moderna
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
MITテクノロジーレビュー13 日
米FDA、新型コロナワクチンを高齢者らに限定 その合理性は？
米国食品医薬品局（FDA）は、新型コロナウイルス・ワクチンの接種を高齢者や重症化リスクが高い人に制限する方針を発表した。この判断は妥当なのか？ 専門家に話を聞いた。 by Jessica Hamzelou 2025.05.26 ...
COVID Concerns: FDA’s New Vaccine Guidelines Raise Questions
The FDA’s decision comes at a time when the number of cases of COVID variant NB.1.8.1 have been rising globally, which ...
PharmTech5 日
FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE
A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.
New COVID vaccine approved by US FDA: Here's all about it
The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...
FDA changing COVID vaccine guidelines. An NC doctor says who can still get it
The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. A North Carolina doctor says ...
The Japan Times12 日Opinion
The FDA’s new COVID-19 vaccine policy is clear as mud
The U.S. health agency's promises of transparency and choice for COVID-19 vaccines fall short in its first big test.
The Cardiology Advisor2 日
FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice
Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster ...